These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 12476295)
1. Unrelated bone marrow transplantation for leukocyte adhesion deficiency. Farinha NJ; Duval M; Wagner E; Champagne J; Lapointe N; Barrette S; Tapiero B; Busque L; Champagne MA Bone Marrow Transplant; 2002 Dec; 30(12):979-81. PubMed ID: 12476295 [TBL] [Abstract][Full Text] [Related]
2. Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency. Mancias C; Infante AJ; Kamani NR Bone Marrow Transplant; 1999 Dec; 24(11):1261-3. PubMed ID: 10642820 [TBL] [Abstract][Full Text] [Related]
3. Matched unrelated bone marrow transplantation with reduced-intensity conditioning for leukocyte adhesion deficiency. Engel ME; Hickstein DD; Bauer TR; Calder C; Manes B; Frangoul H Bone Marrow Transplant; 2006 Apr; 37(7):717-8. PubMed ID: 16489359 [No Abstract] [Full Text] [Related]
4. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft. Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494 [TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation for leukocyte adhesion deficiency-I: case report. Al-wahadneh AM; Haddadin I; Hamouri M; Omari K; Aejellat F Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):564-7. PubMed ID: 17186693 [TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282 [TBL] [Abstract][Full Text] [Related]
7. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic stem cell transplantation from related and unrelated donors for aplastic anaemia in adults--a single-centre experience. Buchholz S; Dammann E; Koenecke Ch; Stadler M; Franzke A; Blasczyk R; Bremer M; Krauter J; Hertenstein B; Ganser A; Eder M Ann Hematol; 2008 Jul; 87(7):551-6. PubMed ID: 18386010 [TBL] [Abstract][Full Text] [Related]
9. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies. Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920 [TBL] [Abstract][Full Text] [Related]
10. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. Schleuning M; Günther W; Tischer J; Ledderose G; Kolb HJ Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194 [TBL] [Abstract][Full Text] [Related]
12. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion. Bunin N; Aplenc R; Iannone R; Leahey A; Grupp S; Monos D; Pierson G Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the outcomes of allogeneic bone marrow transplantation from partially mismatched related donors, matched sibling donors, and matched unrelated donors in Japanese pediatric patients: a single center result. Nagatoshi Y; Kawano Y; Okamura J Pediatr Transplant; 2004 Jun; 8(3):260-6. PubMed ID: 15176964 [TBL] [Abstract][Full Text] [Related]
14. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M; Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR; Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337 [TBL] [Abstract][Full Text] [Related]
16. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP; J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940 [TBL] [Abstract][Full Text] [Related]
17. Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma. Bruno B; Sorasio R; Patriarca F; Montefusco V; Guidi S; Busca A; Scimé R; Console G; Milone G; Marotta G; Dominietto A; Giaccone L; Rotta M; Falda M; Bacigalupo A; Bosi A; Corradini P; Fanin R; Pollichieni S; Boccadoro M; Eur J Haematol; 2007 Apr; 78(4):330-7. PubMed ID: 17331132 [TBL] [Abstract][Full Text] [Related]
18. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor. Chim CS; Lie AK; Liang R; Au WY; Kwong YL Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712 [TBL] [Abstract][Full Text] [Related]
19. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]. Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125 [TBL] [Abstract][Full Text] [Related]
20. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Lee JH; Choi SJ; Lee JH; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Lee KH Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]